Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01262755 · ClinicalTrials.gov registry record

Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology

A clinical trial, sponsored by Temple University.

Completed
Registry status
450
Enrollment target

NCT01262755: Completed study, sponsored by Temple University.

NCT01262755 is a clinical trial that has completed, run by Temple University. The registered enrollment target is 450 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01262755 has completed, sponsored by Temple University.

COMPLETED
Registry status
450 participants
Enrollment target

Study Summary

DESCRIPTION: Minimal data exists on the prevalence of gastroesophageal reflux disease in minority populations. Specific objectives of this K24 research project are to: (1) Provide an estimate of the prevalence of gastroesophageal reflux disease in an urban, African American population; (2) Determine whether specific risk factors including diet, tobacco use, physical activity, and psychosocial stress are important in the targeted population. We will also measure height, weight, and waist/hip circumference to determine the impact of central obesity on reflux. PUBLIC HEALTH RELEVANCE: This research will help doctors to understand the frequency and risks for esophageal reflux disease (heartburn) in African Americans.

Primary Outcome

Patients will complete a series of standardized questionnaires to determine the prevalence of reflux disease and risk factors for its development. We will query diet, depression, drug, tobacco, and alcohol use as well as a variety of other factors. We will study 450 African Americans living in North Philadelphia.

Interventions

  • BEHAVIORAL Structured Interview

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2010-04
Est. Completion 2015-01
Temple University

163 total trials

What the finished NCT01262755 record still lists

NCT01262755 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Structured Interview is the first listed.

NCT01262755 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01262755 about?

NCT01262755 is a clinical study titled "Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology". DESCRIPTION: Minimal data exists on the prevalence of gastroesophageal reflux disease in minority populations. Specific objectives of this K24 research project are to: (1) Provide an estimate of the prevalence of gastroesophageal reflux disease in an urban, African American population; (2) Determine...

What is the current status of trial NCT01262755?

This trial is currently completed. The enrollment target is 450 participants. The study started on 2010-04. Estimated completion is 2015-01.

What interventions are being tested in trial NCT01262755?

The interventions under investigation include: Structured Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT01262755?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01262755, the US trial registry maintained by the National Library of Medicine. NCT01262755 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.